Tag: AbbVie Inc

AI stocks rebound, and why J&J’s earnings guidance cut is not cause for concern

What to know about testosterone replacement therapy as the U.S. military plans to test troops

The market for psychedelic drugs to treat mental health conditions gets a big buy signal

J&J falls despite a beat-and-raise quarter. Why we’re raising our price target anyways

‘Mag 7’ earnings, Fed meeting will test a stock market near all-time highs. Here’s what’s ahead

Trump tariff fallout: Some industries grapple with lingering effects one year later

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Healthy Returns: Botox, Trulicity among 15 drugs added to Medicare price negotiations

Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference